Viewing Study NCT03263767


Ignite Creation Date: 2025-12-25 @ 12:52 AM
Ignite Modification Date: 2026-01-01 @ 4:46 PM
Study NCT ID: NCT03263767
Status: TERMINATED
Last Update Posted: 2022-07-15
First Post: 2017-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC
Sponsor: Nantes University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graft Versus Host Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Peripheral haemopoietic stem cell transplant View
None High dose cyclophosphamide View
None acute GVHD View
None allogenic transplantation View
None RIC (reduced-intensity conditioning) View